`Tel: 571.272.7822
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`PRAXAIR DISTRIBUTION, INC.
`Petitioner
`
`v.
`
`MALLINCKRODT HOSPITAL PRODUCTS IP LTD.,
`Patent Owner
`
`Case IPR2015-00529
`Patent 8,846,112
`
`PETITIONER’S UPDATED MANDATORY NOTICES
`37 C.F.R. § 42.8
`
`
`
`IPR2015-00529
`U.S. Patent No. 8,846,112
`
`Pursuant to 37 C.F.R. § 42.8, Petitioner submits the following updated
`
`mandatory notices.
`
`Related Matters
`
`In the related, pending lawsuit Mallinckrodt Hospital Products IP Ltd., et al.
`
`v. Praxair Distribution, Inc., et al., Civil Action No. 1:15-cv-00170 (GMS), Judge
`
`Sleet
`
`issued his Markman order on July 5, 2016 construing the term
`
`“pharmaceutically acceptable nitric oxide gas.” In the Order, Judge Sleet stated
`
`“[t]he term ‘pharmaceutically acceptable nitric oxide gas’ is non-limiting, so no
`
`construction is necessary.” (D.I. 131 at 1.)
`
`No other information provided as part of Petitioner’s Mandatory Notices in
`
`this proceeding has changed.
`
`Date: July 5, 2016
`
`Respectfully Submitted,
`
`By: /Sanjay K. Murthy/
`Sanjay K. Murthy
`Reg. No. 45,976
`Morgan, Lewis & Bockius LLP
`77 West Wacker Drive, Fifth Floor
`Chicago, IL 60601
`sanjay.murthy@morganlewis.com
`T: (312) 324-1448
`F: (312) 324-1001
`
`1
`
`
`
`Certification of Service Under 37 C.F.R. § 42.6(e)(4)
`
`A copy of this Updated Mandatory Notice has been served to counsel for the
`
`Patent Owner at the following email addresses on this 5th day of July, 2016:
`
`Bob Steinberg
`Bob.steinberg@lw.com
`
`David Callahan
`David.callahan@lw.com
`
`Marc Zubick
`Marc.zubick@lw.com
`
`Daniel Brown
`Daniel.brown@lw.com
`
`Kenneth Schuler
`Kenneth.schuler@lw.com
`
`Respectfully Submitted,
`
`By: /Sanjay K. Murthy/
`Sanjay K. Murthy
`Reg. No. 45,976
`Morgan, Lewis & Bockius LLP
`77 West Wacker Drive, Fifth Floor
`Chicago, IL 60601
`sanjay.murthy@morganlewis.com
`T: (312) 324-1448
`F: (312) 324-100